Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Janet Wale"'
Autor:
John Bashford, Stephen Hancock, Alexander G. Heriot, David C. Currow, John Coutsouvelis, Phoebe Zhang, Jon Emery, Carmel O’Kane, Jeremy Millar, Eva Segelov, John Zalcberg, Brian T. Collopy, Christine Carrington, Sanchia Aranda, Anthony J Sulkowski, Simon J. Cooper, Linda Mileshkin, Janet Wale
INTRODUCTION: The Australian Council on Healthcare Standards (ACHS) sponsored an expert-led, consensus-driven, four-stage process, based on a modified Delphi methodology, to determine a set of clinical indicators as quality measures of cancer service
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dc35926b7d24863eaee01b694334b0a
https://hdl.handle.net/10453/155514
https://hdl.handle.net/10453/155514
Autor:
Wouter Hamelinck, Elita Poplavska, Ott Laius, Ruaraidh Hill, Jurij Fürst, Dzintars Gotham, Iva Selke Krulichová, Zornitza Mitkova, Ileana Mardare, Andrew F. Hill, Stuart McTaggart, Brian Godman, Corrine Zara, Vanda Marković-Peković, Patricia Vella Bonanno, Mark Parker, Caridad Pontes, Katarina Banasova, Tanja Novakovic, John Yfantopoulos, Janet Wale, Irene Langner, Hans Piepenbrink, Christian Hierländer, Peter Skiold, Guenka Petrova, Magdalene Wladysiuk, Amanj Kurdi, Vincent de Valk, Stephen Campbell, Anna Nachtnebel, Admir Malaj, Roberta Joppi, Angela Timoney, Maria Juhasz-Haverinen, Antony P. Martin, Jolanta Gulbinovič, Merce Obach Cortadellas, Iris Hoxha, Arianit Jakupi, Durhane Wong-Rieger, Catherine Sermet, D Tomek, Gisbert Selke, Eleonora Allocati, Ieva Greiciute-Kuprijanov, Tomasz Bochenek, Steven Simoens, Robert Plisko
Publikováno v:
University of Strathclyde
Introduction/Objectives: Health authorities are facing increasing challenges to the sustainability of their healthcare systems because of the growing expenditures on medicines, including new, high-priced oncology medicines, and changes in disease pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77151d4ac5e7399df29d92a7faac2a6
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf
Autor:
Ruaraidh Hill, Christian Hierländer, Carolina Zampirolli Dias, Tomasz Bochenek, Ott Laius, Lars L. Gustafsson, Tracey-Lea Laba, Arianit Jakupi, Øyvind Melien, Wija Oortwijn, Luka Voncina, Durhane Wong-Rieger, Caridad Pontes, Jf Hans Piepenbrink, Magdalene Wladysiuk, Guenka Petrova, Patricia Vella Bonanno, Corinne Zara, Robert Sauermann, Steven Simoens, Olayinka O Ogunleye, Amanj Kurdi, Wouter Hamelinck, Wania Cristina Silva, Dzintars Gotham, Seung Jin Bae, Johanna C Meyer, Roberta Joppi, Janet Wale, Admir Malaj, John Yfantopoulos, Gisbert Selke, Angela Timoney, Brian Godman, Vincent de Valk, Andrew Hill, Merce Obach Cortadellas, D Tomek, Hye-Young Kwon, Irene Langner, Jurij Fürst, Iva Selke Krulichová, Antony P. Martin, Jolanta Gulbinovič, Iris Hoxha, Eleonora Allocati, Stuart McTaggart, Ieva Greiciute-Kuprijanov, Vanda Marković-Peković, Ileana Mardare
Publikováno v:
Expert review of pharmacoeconomics and outcomes research, Abingdon : Taylor and Francis Ltd., 2021, vol. 21, iss. 4, p. 527-540
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research
Introduction: There are growing concerns among European health authorities regarding increasing prices for new cancer medicines, prices not necessarily linked to health gain and the implications for the sustainability of their healthcare systems. Are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfe77330e4296c7333cde6b78e19b86
https://repository.vu.lt/VU:ELABAPDB88291411&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB88291411&prefLang=en_US
Autor:
Stuart McTaggart, Irene Langer, Ieva Greiciute-Kuprijanov, Patricia Vella Bonanno, Anne Marthe Ringerud, Angela Timoney, Jurij Fürst, John Yfantopoulos, Arianit Jakupi, Tatjana Ponorac, Robert Sauermann, Vanda Marković-Peković, Dzintars Gotham, D Tomek, Admir Malaj, Corinne Zara, Christian Hierländer, Peter Skiold, Vincent de Valk, Guenka Petrova, Antony P. Martin, JF (Hans) Piepenbrink, Jolanta Gulbinovič, Janet Wale, Iris Hoxha, Wouter Hamelinck, Maria Juhasz-Haverinen, Nataša Grubiša, Steven Simoens, Catherine Sermet, Ott Laius, Gisbert Selke, Robert Plisko, Celia C. Rothe, Tomasz Bochenek, Andrew F. Hill, Tanja Novakovic, Zornitza Mitkova, Ileana Mardare, Alan Haycox, Roberta Joppi, Carolin Hagen, Magdalene Wladysiuk, Amanj Kurdi, Elita Poplavska, Brian Godman, Merce Obach Cortadellas, Mark Parker
Publikováno v:
Generics and Biosimilars Initiative Journal
Introduction: There are appreciable concerns among European health authorities with growing expenditure on cancer medicines and issues of sustainability. The enhanced use of low cost generics could help. Aims: Consequently, there is a need to compreh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0009ea13d1e0e5433c3f43ffb8a0034b
https://ruj.uj.edu.pl/xmlui/handle/item/257394
https://ruj.uj.edu.pl/xmlui/handle/item/257394
Autor:
Janet Wale, Tricia Greenway, Jane Scoble, Vesna Grubacevic, Kylie O'Brien, Keryn Coghill, Amber Moore, Sitalakshmi Venkatraman, Leslie Gilham, Sally Percival-Smith
Publikováno v:
European Journal of Integrative Medicine. 33:101004
Introduction It is known that complementary and alternative medicine (CAM) use can be high in people with cancer. Despite a plethora of information about CAMs on the internet, reliable, evidence-based information about potential interactions between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be08a9ac86f04673fcb5166a56ebe97e
https://doi.org/10.1016/j.eujim.2019.101004
https://doi.org/10.1016/j.eujim.2019.101004
Publikováno v:
Hospital-Based Health Technology Assessment ISBN: 9783319392035
Policy makers, healthcare managers, and HTA producers are increasingly interested in exploring strategies for involving the public and patients in HTA activities [1, 7]. While public involvement in HTA can be a response to the need for more transpare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::314b8d9e47599fed59b10884d8caae57
https://doi.org/10.1007/978-3-319-39205-9_30
https://doi.org/10.1007/978-3-319-39205-9_30
Autor:
Nancy Santesso, Peter Tugwell, Michelle Driedger, Elizabeth Kristjansson, Monica Prince, George A. Wells, Peter Brooks, Andrew Wilson, Annette M. O'Connor, Cindy Gallois, Janet Wale, Anne Lyddiatt, Vivian Welch, Gráinne O'Leary, Tamara Rader, Dawn Stacey
Publikováno v:
The Journal of Rheumatology. 36:2087-2091
Objective.The Effective Consumer Scale (EC-17) comprises 17 items measuring the main skills and behaviors people need to effectively manage their healthcare. We tested the responsiveness of the EC-17.Methods.Participants, in 2 waves of a 6-week Arthr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a15703e786f49cdf84df5d9080260176
https://doi.org/10.3899/jrheum.090363
https://doi.org/10.3899/jrheum.090363
Publikováno v:
Australian health review : a publication of the Australian Hospital Association. 41(2)
At a health system level, the importance of patient and public input into healthcare decision making is well recognised. Patient and public involvement not only provides a mechanism to legitimise decisions, but also contributes to improved translatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4771929aced4c34f8855657776f0bf47
https://pubmed.ncbi.nlm.nih.gov/27224935
https://pubmed.ncbi.nlm.nih.gov/27224935
Autor:
Rickard E. Malmström, Hanne Bak Pedersen, Marija Kalaba, Anna Bucsics, Kristina Garuoliene, Laura McCullagh, Ali Alkan, Vera Vlahović-Palčevski, Elif Hilal Vural, Azuwana Supian, Kaisa Miikkulainen, Stephen Campbell, Einar Magnisson, Eduardo Diogene, Sisira Jayathissa, Faridah Yusof, Alexander E. Finlayson, Augusto Afonso Guerra Junior, Susan Spillane, Wenjie Zeng, Irene Eriksson, Low Ee Vien, Gabriela Ofierska-Sujkowska, Winnie de Bruyn, Angela Timoney, Anna Brzezinska, Lars L. Gustafsson, Janet Wale, Catherine Sermet, Gisbert Selke, Jurij Fürst, Saira Jan, Jadwiga Czeczot, Andy Gray, Roberta Joppi, Francisco de Assis Acurcio, Jolanta Gulbinovič, Brian Godman, Magdalene Wladysiuk, Ilse Truter
Publikováno v:
Expert review of clinical pharmacology. 8(1)
Medicines have made an appreciable contribution to improving health. However, even high-income countries are struggling to fund new premium- priced medicines. This will grow necessitating the development of new models to optimize their use. The objec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148287e03c07bbe158f8a550d7095527
https://pubmed.ncbi.nlm.nih.gov/25487078
https://pubmed.ncbi.nlm.nih.gov/25487078
Autor:
Diana MacDonell, Xiao Zhang, Anand Jha, Gilberto Lopes, Dong-Churl Suh, Lucy Hickinbotham, Ekaphop Sirachainan, Jasmine Roah Fang Pwu, Hwee Lin Wee, Salmah Bahri, Durhane Wong-Rieger, Ruby Shih, Bor-Sheng Ko, Janet Wale, Swee Sung Soon, Hwee Yong Lim
Publikováno v:
Orphanet Journal of Rare Diseases
This article is a call for action to the relevant stakeholders to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region by looking into three main areas: (a) developing legislative definitions to confer enfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47293923ca322b48913c593c40632767
https://doi.org/10.1186/s13023-014-0137-1
https://doi.org/10.1186/s13023-014-0137-1